Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
21/04/2026 16:52
April 21 (Reuters) - Scope Fluidics SA SCPP.WA: UNIT BACTEROMIC STARTS COLLABORATION WITH US RESEARCH CENTER FOR FDA REGISTRATION TRIALS TRIALS TO TEST BACTEROMIC SYSTEM WITH EXPANDED UNI FAST PANEL COVERING UP TO 52 ANTIBIOTICS CLINICAL TRIAL RESULTS ARE REQUIRED FOR FDA SUBMISSION Source text: ID:nEM3q8jhCa Further company coverage: SCPP.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics' EDOCERA Project Meets Second Goal Of Developing Prototype Of Device For Detecting Stroke Symptoms
Brief: Scope Fluidics Q2 Net Loss At 10.1 Million Zlotys
Brief: Scope Fluidics Unit Signs Deal With Poland's PARP For Up To 14.4 Mln Zlotys In Funding For HYBOLIC Project
Brief: Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027
Brief: Scope Fluidics Extends Deadline For First Goal In Hybolic Project